Loading...
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
INTRODUCTION: Efficacy of mepolizumab, an anti-interleukin-5 monoclonal antibody, was demonstrated in randomised controlled trials; data on its real-world impact in routine clinical practice are starting to emerge. We assessed the effectiveness and safety of mepolizumab prescribed for patients in th...
Na minha lista:
| Udgivet i: | Eur Respir J |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
European Respiratory Society
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7559868/ https://ncbi.nlm.nih.gov/pubmed/32817259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00151-2020 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|